Nov 24, 2024 07:27PM
Nov 13, 2023 04:05PM
Oct 24, 2023 06:59AM
Oct 24, 2023 06:59AM
Aug 28, 2023 04:05PM
Aug 28, 2023 04:05PM
Aug 14, 2023 04:05PM LianBio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Jul 26, 2023 08:30AM
Jul 26, 2023 08:30AM
Jul 17, 2023 06:00AM
Jun 26, 2023 08:00AM
Jun 8, 2023 07:00AM
May 11, 2023 07:03AM
May 11, 2023 07:00AM LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in the Macau Special Administrative Region (SAR) of China
Apr 26, 2023 08:00AM
Apr 26, 2023 08:00AM
Apr 24, 2023 07:33PM
Apr 21, 2023 08:01AM
Apr 21, 2023 08:00AM
Mar 27, 2023 08:36AM
Mar 23, 2023 07:30AM BridgeBio Pharma Announces First Lung Cancer Patient Dosed in Phase 1 Trial for SHP2 Inhibitor BBP-398 in Combination with Bristol Myers Squibb’s OPDIVO® (nivolumab)
Dec 19, 2022 07:06AM
Dec 19, 2022 07:00AM
Nov 10, 2022 04:05PM
Nov 9, 2022 04:15PM
Nov 9, 2022 07:00AM
Nov 3, 2022 07:30AM
Nov 1, 2022 04:05PM LianBio Doses First Patient in Registrational Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitis
Oct 16, 2022 10:00PM
Oct 11, 2022 07:30AM
Sep 28, 2022 04:15PM
Sep 7, 2022 04:15PM
Aug 11, 2022 04:05PM
Aug 10, 2022 08:00AM
Jul 1, 2022 08:40AM Centessa Pharmaceuticals Announces Appointment of Dr. Mathias Hukkelhoven to its Board of Directors
May 18, 2022 09:12PM
May 18, 2022 04:40PM
May 12, 2022 08:00AM
May 10, 2022 04:05PM
May 10, 2022 07:00AM
May 9, 2022 08:00AM
May 3, 2022 08:00AM LianBio's (LIAN) Partner Tarsus Pharmaceuticals Announces Positive Topline Data from Second Pivotal Trial of TP-03
May 3, 2022 08:00AM
Apr 29, 2022 08:16AM
Apr 29, 2022 08:15AM
Apr 14, 2022 04:10PM
Mar 30, 2022 04:39PM
Mar 24, 2022 04:45PM
Mar 14, 2022 04:05PM Tarsus Pharmaceuticals, Inc. Reports Full-Year 2021 Financial Results and Recent Business Achievements
Mar 3, 2022 07:32AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All